STL to distribute next gen payment solution in Australia and New Zealand

Published 31-AUG-2016 11:03 A.M.


1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

A five year distribution deal for EFTPOS terminals and software has been signed between Stargroup’s (ASX:STL) 100% owned subsidiary StarApps, and West International AB.

According to STL Founder and CEO Todd Zani, the partnership with Swedish NASDAQ OMX First North Exchange listed West International AB gives STL a competitive edge in a number of merchant sectors through the use of West’s technology and more importantly being in control of the source code within the terminals.

As part of the agreement StarApps will acquire 2000 EFTPOS terminals per year and develop unique EFTPOS software solutions and applications in the Australian and New Zealand market place.

The Australian EFTPOS market is experiencing sustained growth year-on-year with around 60,000 terminals being installed each year. Currently there are approximately 900,000 EFTPOS terminals in operation throughout the country.

A positive sign for STL who has achieved 10 consecutive quarters of revenue growth with projected annualised revenue in FY2017 to reach $11.4m.

There is no guarantee that revenues will continue to come in for STL or that the deal signed with West International AB will lead to commercial success, so investors looking at STL’s figures should still take a caution approach to their investment decision and seek professional financial advice.

The strong revenues has STL planning to make its maiden dividend payment in the 2017 financial year.

STL currently has 395 EFTPOS terminals in operation and also owns an 11.28% strategic stake in industry leading ATM manufacturer NeolCP.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free